DE1214674B - Verfahren zur Herstellung von Guanidinderivaten - Google Patents

Verfahren zur Herstellung von Guanidinderivaten

Info

Publication number
DE1214674B
DE1214674B DEE27090A DEE0027090A DE1214674B DE 1214674 B DE1214674 B DE 1214674B DE E27090 A DEE27090 A DE E27090A DE E0027090 A DEE0027090 A DE E0027090A DE 1214674 B DE1214674 B DE 1214674B
Authority
DE
Germany
Prior art keywords
blood pressure
shows
guanethidine
effect
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEE27090A
Other languages
German (de)
English (en)
Inventor
Wilfred James Cecil Dyke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma Ltd
Original Assignee
Evans Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evans Medical Ltd filed Critical Evans Medical Ltd
Publication of DE1214674B publication Critical patent/DE1214674B/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
DEE27090A 1963-12-13 1964-05-22 Verfahren zur Herstellung von Guanidinderivaten Pending DE1214674B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB49408/63A GB1110947A (en) 1963-12-13 1963-12-13 Guanidines

Publications (1)

Publication Number Publication Date
DE1214674B true DE1214674B (de) 1966-04-21

Family

ID=10452240

Family Applications (1)

Application Number Title Priority Date Filing Date
DEE27090A Pending DE1214674B (de) 1963-12-13 1964-05-22 Verfahren zur Herstellung von Guanidinderivaten

Country Status (8)

Country Link
US (1) US3409669A (is)
BE (1) BE656923A (is)
CH (1) CH471071A (is)
DE (1) DE1214674B (is)
FR (1) FR3889M (is)
GB (1) GB1110947A (is)
NL (1) NL6413937A (is)
SE (1) SE331090B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385946A (en) * 1986-07-10 1995-01-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Method for treating hypertension with disubstituted granidine compounds
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5336689A (en) * 1990-03-02 1994-08-09 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
DE69133065T2 (de) 1990-03-02 2003-02-27 Oregon State Tri- und tetra-substituierte guanidine und deren verwendung als antagonisten von exzitatorischen aminosäuren
AU653729B2 (en) * 1990-05-25 1994-10-13 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Substituted guanidines having high binding to the sigma receptor and the use thereof
DE69233479T2 (de) * 1991-02-08 2006-03-16 Scion Pharmaceuticals, Inc., Medford Substituierte Guanidine und Derivate hiervon als Modulatoren der Freisetzung von Neurotransmittern und neue Methode zur Identifizierung von Inhibitoren der Neurotransmitter-Freisetzung
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
CA2163361C (en) * 1993-05-27 2008-06-17 Graham J. Durant Therapeutic substituted guanidines
CA2177081A1 (en) * 1993-11-23 1995-06-01 Graham J. Durant Therapeutic substituted guanidines
EP0751767A4 (en) 1994-02-03 1997-12-10 Cambridge Neuroscience Inc GUANIDINE FOR THERAPEUTIC USE
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3291829A (en) * 1961-03-02 1966-12-13 Ciba Geigy Corp Alkyl guanidines

Also Published As

Publication number Publication date
US3409669A (en) 1968-11-05
FR3889M (is) 1966-01-31
GB1110947A (en) 1968-04-24
CH471071A (de) 1969-04-15
SE331090B (is) 1970-12-14
BE656923A (is) 1965-06-10
NL6413937A (is) 1965-06-14

Similar Documents

Publication Publication Date Title
DE1214674B (de) Verfahren zur Herstellung von Guanidinderivaten
DE1670536B2 (de) Neue 2-Anilino-5-acylamino-pyrimidlne
DE1212106B (de) Verfahren zur Herstellung von analeptisch wirksamen 2-Phenoxy-2-phenylaethylaminen
DE2207184A1 (de) Verfahren zur reinigung von acrylsaeure
DE3102769A1 (de) "bis-moranolinderivate"
CH507277A (de) Verfahren zur Herstellung neuer substituierter 3-Amino-sydnonimine
DE1185194B (de) Verfahren zur Herstellung von Abkoemmlingen des Salicylsaeureamides
DE1158083B (de) Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
CH356121A (de) Verfahren zur Herstellung von N-monosubstituierten Amiden vona-Aminoalkyl-a-phenyl-essigsäuren
DE1670143C3 (is)
AT232500B (de) Verfahren zur Herstellung von neuen Phenylalaninderivaten
AT322563B (de) Verfahren zur herstellung von neun 6-substituierten 3-hydrazinopyridazinen und deren säureadditionssalzen
AT231426B (de) Verfahren zur Herstellung von neuen cyclischen Aminen und deren Salzen
DE1543900C3 (de) N-Phenyl-N-(3-alkoxy-2-hydroxy)-propylamine und Verfahren zu deren Herstellung, sowie diese Verbindungen enthaltende Arzneimittel
DE1222048B (de) Verfahren zur Herstellung von eine oder mehrere Sulfongruppen enthaltenden organischen Verbindungen
AT356665B (de) Verfahren zum herstellen neuer chinuclidin- derivate, ihren stereoisomeren, optischen isomeren und salzen
CH409974A (de) Verfahren zur Herstellung neuer therapeutisch wirksamer Coffeino-(8)-alkylendiamine
AT300763B (de) Verfahren zur Herstellung von neuen 5-(1'-Hydroxy-2'-arylalkyl-oder -aryloxyalkylaminoäthyl)-salicylamiden und deren Säureadditionssalzen
AT234686B (de) Verfahren zur Herstellung des neuen 2-(2',4',6'-Trimethylbenzyl)-1,3-diazacyclopentens-(2)
DE1595903C (de) 1-Substituierte 2,6-Dimethyl-4-phenylpiperazine
AT237597B (de) Verfahren zur Herstellung von neuen Propylaminderivaten und deren Salzen
DE1930827A1 (de) Neue Formamido-cycloalkanderivate
DE1064049B (de) Verfahren zur Herstellung von analgetisch wirksamen, N-substituierten beta-Oxybuttersureamiden
AT214931B (de) Verfahren zur Herstellung von neuen 1-Carbamylazetidinen
AT214910B (de) Verfahren zur Herstellung von neuen, am Stickstoffatom und am β-Kohlenstoffatom substituierten Buttersäureamiden